s-892216
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 17, 2024 (NCT06751017)
Timeline
Indications
Mechanism of action
- Replicase polyprotein 1abINHIBITOR
rep inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07217886 | Phase 1 | Oct 16, 2025 | Department of Health and Human Services, Shionogi |
| NCT07093580 | Phase 1 | Jul 29, 2025 | Shionogi |
| NCT06928051 | Phase 2 | Jun 6, 2025 | Shionogi |
| NCT06751017 | Phase 1 | Dec 17, 2024 | Shionogi |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shionogi | For profit | 4 | 4 | 2 | 2024 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1